Indo US Bio-Tech

{
  "main_header": {
    "sid": 1002989,
    "name": "Indo US Bio-Tech",
    "stock_name": "Indo US Bio-Tech",
    "full_name": "Indo US Bio-Tech Ltd",
    "name_url": "stocks-analysis/indo-us-bio-tech",
    "exchange": 0,
    "exchangecode": "",
    "country_id": 34,
    "currency": "INR",
    "cmp": "110.15",
    "chg": -0.05,
    "chgp": "-0.05%",
    "dir": -1,
    "prev_price": "110.20",
    "mcapval": "228.00 Cr",
    "mcap": "Micro Cap",
    "scripcode": 541304,
    "symbol": "INDOUS",
    "ind_name": "Other Agricultural Products",
    "ind_code": 61,
    "indexname": "",
    "isin": "INE250Z01010",
    "curr_date": "Jan 19",
    "curr_time": "",
    "bse_nse_vol": "34.35 k",
    "exc_status": "Active",
    "traded_date": "Jan 19, 2026",
    "traded_date_str": "2026 01 19",
    "score": "",
    "scoreText": "",
    "Live": 0,
    "market_time": 1,
    "is_blur": 1,
    "is_blur_class": "blur-register-score-header",
    "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/indo-us-bio-tech-1002989-0&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0
    }
  },
  "news": {
    "results": [
      {
        "title": "Indo US Bio-Tech Downgraded to Sell Amid Technical Weakness and Flat Financials",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/indo-us-bio-tech-downgraded-to-sell-amid-technical-weakness-and-flat-financials-3795521",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/1/IndoUSBioTechLt_mojoScore_3795521.png",
        "date": "2026-01-20 08:30:06",
        "description": "Indo US Bio-Tech Ltd, a player in the Other Agricultural Products sector, has seen its investment rating downgraded from Hold to Sell as of 19 Jan 2026. This shift reflects deteriorating technical indicators, flat recent financial performance, and a challenging near-term outlook despite some strong long-term fundamentals. The company’s Mojo Score has declined to 47.0, signalling caution for investors amid a 3.8% drop in share price on the downgrade day."
      },
      {
        "title": "Indo US Bio-Tech Ltd Falls to 52-Week Low Amidst Continued Market Pressure",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/indo-us-bio-tech-ltd-falls-to-52-week-low-amidst-continued-market-pressure-3794776",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/1/IndoUSBioTechLt_priceRelatedfactors_3794776.png",
        "date": "2026-01-19 15:41:07",
        "description": "Indo US Bio-Tech Ltd, a player in the Other Agricultural Products sector, touched a fresh 52-week low of Rs.110.15 today, marking a significant decline amid broader market weakness and sector underperformance. The stock’s fall reflects ongoing pressures despite some underlying financial strengths."
      },
      {
        "title": "When is the next results date for Indo US Bio-Tech Ltd?",
        "link": "https://www.marketsmojo.com/news/result-analysis/when-is-the-next-results-date-for-indo-us-bio-tech-ltd-3790617",
        "imagepath": "",
        "date": "2026-01-13 23:16:11",
        "description": "The next results date for Indo US Bio-Tech Ltd is scheduled for January 21, 2026...."
      },
      {
        "title": "Indo US Bio-Tech Ltd is Rated Sell",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/indo-us-bio-tech-ltd-is-rated-sell-3789655",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/1/IndoUSBioTechLt_mojoScore_3789655.png",
        "date": "2026-01-12 10:10:52",
        "description": "Indo US Bio-Tech Ltd is rated Sell by MarketsMOJO, with this rating last updated on 05 January 2026. However, the analysis and financial metrics presented here reflect the stock's current position as of 12 January 2026, providing investors with the most up-to-date view of the company’s performance and outlook."
      },
      {
        "title": "Indo US Bio-Tech Ltd Upgraded to Hold as Technicals Improve Amid Mixed Financials",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/indo-us-bio-tech-ltd-upgraded-to-hold-as-technicals-improve-amid-mixed-financials-3774474",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/12/IndoUSBioTechLt_mojoScore_3774474.png",
        "date": "2025-12-30 08:56:23",
        "description": "Indo US Bio-Tech Ltd has seen its investment rating upgraded from Sell to Hold as of 29 Dec 2025, reflecting a nuanced improvement in technical indicators, valuation metrics, and financial trends despite recent flat quarterly performance. This shift highlights a cautious optimism among analysts amid ongoing market challenges and the company’s attractive long-term fundamentals."
      },
      {
        "title": "Indo US Bio-Tech Faces Market Challenges Amid Mixed Financial and Technical Signals",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/indo-us-bio-tech-downgraded-to-sell-amid-weak-technicals-and-flat-financials-3767855",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/12/IndoUSBioTech_mojoScore_3767855.png",
        "date": "2025-12-24 08:23:20",
        "description": "Indo US Bio-Tech, a player in the Other Agricultural Products sector, is currently navigating a complex market environment marked by subdued financial results, shifting technical indicators, and valuation contrasts. Recent assessment changes reflect a nuanced view of the company’s prospects amid broader market dynamics."
      },
      {
        "title": "Indo US Bio-Tech Sees Revision in Market Evaluation Amid Mixed Financial Signals",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/indo-us-bio-tech-upgraded-from-sell-to-hold-by-marketsmojo-on-27-nov-2025-3743905",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/12/IndoUSBioTech_mojoScore_3743905.png",
        "date": "2025-12-03 11:08:35",
        "description": "Indo US Bio-Tech, a microcap player in the Other Agricultural Products sector, has experienced a revision in its market evaluation metrics, reflecting nuanced shifts across quality, valuation, financial trends, and technical outlook. This adjustment comes amid a backdrop of mixed financial performance and subdued stock returns over the past year."
      },
      {
        "title": "Why is Indo US Bio-Tech falling/rising?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/why-is-indo-us-bio-tech-fallingrising-3736257",
        "imagepath": "",
        "date": "2025-11-29 01:04:30",
        "description": "    <div class=\"article-news-new\">\n        <div class=\"article-container\">\n\n<div class=\"article-content\">\n\n<p><strong>Intraday Volatility and Price Movement</strong></p>\n<p>The stock experienced significant intraday fluctuations, with a volatility measure of 6.89%, reflecting a turbulent trading session. It touched an intraday low of ₹135, marking an 8.63% drop from previous levels. The weighted average price indicated that a larger volume of shares was traded closer to this lower price point, suggesting selling pressure dominated the session.</p>\n<p><strong>Trend Reversal After Recent Gains</strong></p>\n<p>After two days of consecutive gains, the stock’s fall on 28 Nov represents a clear trend reversal. This shift indicates that the recent buying momentum has paused, and profit-taking or cautious sentiment may have set in among investors. The underperformance relative to its sector, lagging by 7.35% today,..."
      },
      {
        "title": "How has been the historical performance of Indo US Bio-Tech?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/how-has-been-the-historical-performance-of-indo-us-bio-tech-3734112",
        "imagepath": "",
        "date": "2025-11-27 22:45:33",
        "description": "    <div class=\"article-news-new\">\n        <div class=\"article-container\">\n\n<div class=\"article-content\">\n\n<p><strong>Revenue and Profitability Trends</strong></p>\n<p>Over the three-year period ending March 2022, Indo US Bio-Tech's net sales increased from ₹39.76 crores in FY20 to ₹50.06 crores in FY22, reflecting a compound growth trajectory. The total operating income mirrored this trend, with no other operating income reported during these years. Notably, the operating profit before depreciation, interest, and tax (PBDIT) rose from ₹3.98 crores in FY20 to ₹6.95 crores in FY22, indicating enhanced operational efficiency. The operating profit margin improved from 10.01% in FY20 to 13.52% in FY22, underscoring better cost management despite fluctuations in raw material costs and purchase of finished goods.</p>\n<p>Profit before tax (PBT) showed a consistent upward movement, climbing from ₹2.86 crores in FY20..."
      }
    ],
    "total": 211,
    "sid": "1002989",
    "stock_news_url": "https://www.marketsmojo.com/news/indo-us-bio-tech-1002989"
  },
  "announcements": [
    {
      "caption": "Board Meeting Intimation for Consider Approve And Take On Record The Un-Audited Financial Results Of The Company Along With The Limited Review Reports For The Quarter And Nine Months Ended December 31 2025;",
      "datetime": "12-Jan-2026",
      "details": "Indo Us Bio-Tech Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 21/01/2026 inter alia to consider and approve consider approve and take on record the Un-Audited Financial results of the Company along with the Limited Review reports for the Quarter and Nine Months ended December 31 2025; and 2. Any Other Business with the Permission of the Chair. Further as intimated earlier by our letter dated 31st December 2025 captioned intimation for closure of Trading Window the trading window closure period shall remain closed for designated employees/persons (including their immediate relatives) till the expiry of 48 hours after the declaration of Unaudited Financial Results of the Company for the Quarter and Nine Months ended on December 31 2025. The aforesaid information will also be hosted on the Companys website at www.indousagriseeds.com. You are requested to take the same on records. Thanking You",
      "source": "BSE"
    },
    {
      "caption": "Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018",
      "datetime": "07-Jan-2026",
      "details": "Certificate under Reg 74(5) of SEBI DP Reg. for the quarter ended on 31st Dec 2025.",
      "source": "BSE"
    },
    {
      "caption": "Closure of Trading Window",
      "datetime": "31-Dec-2025",
      "details": "Closure of Trading Window",
      "source": "BSE"
    }
  ],
  "corporate_actions": [
    {
      "img": "board-meeting.svg",
      "title": "BOARD MEETING",
      "msg": "",
      "data": [
        {
          "title": "BOARD MEETING",
          "txt": "21 Jan 2026"
        }
      ]
    },
    {
      "img": "dividend.svg",
      "title": "DIVIDEND",
      "msg": "",
      "data": [
        {
          "txt": "Indo US Bio-Tech Ltd has declared <strong>2%</strong> dividend, ex-date: 03 Dec 24",
          "dt": "2024-12-03",
          "middle_text": "Dividend Alert"
        }
      ]
    },
    {
      "img": "splits.svg",
      "title": "SPLITS",
      "msg": "No <strong>Splits</strong> history available",
      "data": []
    },
    {
      "img": "bonus.svg",
      "title": "BONUS",
      "msg": "",
      "data": [
        {
          "txt": "Indo US Bio-Tech Ltd has announced <strong>1:1</strong> bonus issue, ex-date: 29 Aug 23",
          "dt": "2023-08-29",
          "middle_text": "Bonus Alert"
        }
      ]
    },
    {
      "img": "rights-issues.svg",
      "title": "RIGHTS",
      "msg": "No <strong>Rights</strong> history available",
      "data": []
    }
  ]
}

News and Views

Indo US Bio-Tech Downgraded to Sell Amid Technical Weakness and Flat Financials

2026-01-20 08:30:06

Indo US Bio-Tech Ltd, a player in the Other Agricultural Products sector, has seen its investment rating downgraded from Hold to Sell as of 19 Jan 2026. This shift reflects deteriorating technical indicators, flat recent financial performance, and a challenging near-term outlook despite some strong long-term fundamentals. The company’s Mojo Score has declined to 47.0, signalling caution for investors amid a 3.8% drop in share price on the downgrade day.

Read full news article

Indo US Bio-Tech Ltd Falls to 52-Week Low Amidst Continued Market Pressure

2026-01-19 15:41:07

Indo US Bio-Tech Ltd, a player in the Other Agricultural Products sector, touched a fresh 52-week low of Rs.110.15 today, marking a significant decline amid broader market weakness and sector underperformance. The stock’s fall reflects ongoing pressures despite some underlying financial strengths.

Read full news article

When is the next results date for Indo US Bio-Tech Ltd?

2026-01-13 23:16:11

The next results date for Indo US Bio-Tech Ltd is scheduled for January 21, 2026....

Read full news article

Indo US Bio-Tech Ltd is Rated Sell

2026-01-12 10:10:52

Indo US Bio-Tech Ltd is rated Sell by MarketsMOJO, with this rating last updated on 05 January 2026. However, the analysis and financial metrics presented here reflect the stock's current position as of 12 January 2026, providing investors with the most up-to-date view of the company’s performance and outlook.

Read full news article

Indo US Bio-Tech Ltd Upgraded to Hold as Technicals Improve Amid Mixed Financials

2025-12-30 08:56:23

Indo US Bio-Tech Ltd has seen its investment rating upgraded from Sell to Hold as of 29 Dec 2025, reflecting a nuanced improvement in technical indicators, valuation metrics, and financial trends despite recent flat quarterly performance. This shift highlights a cautious optimism among analysts amid ongoing market challenges and the company’s attractive long-term fundamentals.

Read full news article

Indo US Bio-Tech Faces Market Challenges Amid Mixed Financial and Technical Signals

2025-12-24 08:23:20

Indo US Bio-Tech, a player in the Other Agricultural Products sector, is currently navigating a complex market environment marked by subdued financial results, shifting technical indicators, and valuation contrasts. Recent assessment changes reflect a nuanced view of the company’s prospects amid broader market dynamics.

Read full news article

Indo US Bio-Tech Sees Revision in Market Evaluation Amid Mixed Financial Signals

2025-12-03 11:08:35

Indo US Bio-Tech, a microcap player in the Other Agricultural Products sector, has experienced a revision in its market evaluation metrics, reflecting nuanced shifts across quality, valuation, financial trends, and technical outlook. This adjustment comes amid a backdrop of mixed financial performance and subdued stock returns over the past year.

Read full news article

Why is Indo US Bio-Tech falling/rising?

2025-11-29 01:04:30

Intraday Volatility and Price Movement

The stock experienced significant intraday fluctuations, with a volatility measure of 6.89%, reflecting a turbulent trading session. It touched an intraday low of ₹135, marking an 8.63% drop from previous levels. The weighted average price indicated that a larger volume of shares was traded closer to this lower price point, suggesting selling pressure dominated the session.

Trend Reversal After Recent Gains

After two days of consecutive gains, the stock’s fall on 28 Nov represents a clear trend reversal. This shift indicates that the recent buying momentum has paused, and profit-taking or cautious sentiment may have set in among investors. The underperformance relative to its sector, lagging by 7.35% today,...

Read full news article

How has been the historical performance of Indo US Bio-Tech?

2025-11-27 22:45:33

Revenue and Profitability Trends

Over the three-year period ending March 2022, Indo US Bio-Tech's net sales increased from ₹39.76 crores in FY20 to ₹50.06 crores in FY22, reflecting a compound growth trajectory. The total operating income mirrored this trend, with no other operating income reported during these years. Notably, the operating profit before depreciation, interest, and tax (PBDIT) rose from ₹3.98 crores in FY20 to ₹6.95 crores in FY22, indicating enhanced operational efficiency. The operating profit margin improved from 10.01% in FY20 to 13.52% in FY22, underscoring better cost management despite fluctuations in raw material costs and purchase of finished goods.

Profit before tax (PBT) showed a consistent upward movement, climbing from ₹2.86 crores in FY20...

Read full news article

View All News